---
title: "Diabetes I or II Sensor GENESIS | Sutter Health"
description: "GENESIS: next GENEration Sensor Life Study"
url: "https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) /
4.  Diabetes I or II Sensor GENESIS

# Diabetes I or II Sensor GENESIS

**Status:** Open to Enrollment

[Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607#enroll)

#### Locations

-   Burlingame

#### Clinical trial FAQs

Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs).

The study is a multi-center, prospective single-arm design without controls for adult and pediatric subjects with type 1 or type 2 diabetes. All subjects will be assigned to treatment for 7-17 days of sensor wear. Each subject will wear between 1 and 4 sensors, and each will be connected to/integrated with a transmitter. Subjects 2-12 years of age will wear up to 2 study glucose sensors, subjects 13 years and older will wear up to 4 study glucose sensors.

![David Klonoff, M.D.](https://dyn.mktgcdn.com/p/Xzpp7PftRFMKD9YTQZjkaTaWm-XIkkF2w7bCa6jTfF0/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100)

David Klonoff, M.D.

Principal investigator

[View profile](https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885)

## Email us to enroll

-   [Email Burlingame](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Diabetes%20I%20or%20II%20Sensor%20GENESIS%20in%20Burlingame&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.)

## Related clinical trials

[View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial)

-   Clinical trial
    
    ### [Diabetes KOS Argus Continuing Glucose Monitoring System](https://www.sutterhealth.org/research/clinical-trials/diabetes-kos-argus-continuing-glucose-monitoring-system-2082984362)
    
    Argus 2.0 Adoption Study
    
    **Status:** Coming Soon
    
-   Clinical trial
    
    ### [Diabetes MiniMed™ NMX8-AID System Insulin Pump CIP351 GATEWAY](https://www.sutterhealth.org/research/clinical-trials/diabetes-minimed-nmx8-aid-system-insulin-pump-cip351-gateway-2060811280)
    
    GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Type II Diabetes Mellitus ORA-D-013-3](https://www.sutterhealth.org/research/clinical-trials/type-ii-diabetes-mellitus-ora-d-013-3-2068022519)
    
    A Double-Blinded, Placebo-controlled, Double Dummy, Multi-center Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on One to Three Glucose-lowering Agents
    
    **Status:** Coming Soon
    
-   Clinical trial
    
    ### [Diabetes Type II Pediatric ACHIEVE-PEDS J2A-MC-GZGY](https://www.sutterhealth.org/research/clinical-trials/diabetes-type-ii-pediatric-achieve-peds-j2a-mc-gzgy-2084630060)
    
    A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Type 1 Diabetes ONWARDS 11](https://www.sutterhealth.org/research/clinical-trials/type-1-diabetes-onwards-11-2032876855)
    
    A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
    
    **Status:** Open to Enrollment
    

[View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Diabetes I or II Sensor GENESIS"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607#medicalwebpage","name":"Diabetes I or II Sensor GENESIS","description":"GENESIS: next GENEration Sensor Life Study","url":"https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607","inLanguage":"en-US","dateModified":"2026-05-19","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607#breadcrumblist"},"mentions":[{"@type":"Person","name":"David Klonoff, M.D.","url":"https://www.sutterhealth.org/research/investigators/david-klonoff-md-1078064885","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607#medicaltrial","name":"Diabetes I or II Sensor GENESIS","alternateName":"GENESIS: next GENEration Sensor Life Study","url":"https://www.sutterhealth.org/research/clinical-trials/diabetes-i-or-ii-sensor-genesis-2059410607","description":"The study is a multi-center, prospective single-arm design without controls for adult and pediatric subjects with type 1 or type 2 diabetes. All subjects will be assigned to treatment for 7-17 days of sensor wear. Each subject will wear between 1 and 4 sensors, and each will be connected to/integrated with a transmitter. Subjects 2-12 years of age will wear up to 2 study glucose sensors, subjects 13 years and older will wear up to 4 study glucose sensors.","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Diabetes Type 2"},{"@type":"MedicalCondition","name":"Diabetes, Insulin Resistance and Metabolic Syndrome"}],"studyLocation":[{"@type":"AdministrativeArea","name":"Burlingame"}]}
```
